Stay updated on CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page.

Latest updates to the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 in the page footer. This appears to be system versioning information and does not affect study details or user actions.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedFooter now displays Revision: v3.3.3. The HHS Vulnerability Disclosure link was removed, and Revision: v3.3.2 is no longer shown.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now lists Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check63 days agoChange DetectedRemoved the notice about potential delays and NIH operating status due to funding lapse. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check77 days agoChange DetectedThe new screenshot exhibits the same study details with only minor visual and layout adjustments; no substantive edits to the study content or eligibility criteria were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check106 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference5%

Stay in the know with updates to CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page.